title: Atorvastatin attenuates oxidative stress in patients with chronic kidney disease.
authors.forename: Marcin
authors.initials: M
authors.lastname: Renke
authors.forename: Narcyz
authors.initials: N
authors.lastname: Knap
authors.forename: Leszek
authors.initials: L
authors.lastname: Tylicki
authors.forename: Przemyslaw
authors.initials: P
authors.lastname: Rutkowski
authors.forename: Alexander
authors.initials: A
authors.lastname: Neuwelt
authors.forename: Wojciech
authors.initials: W
authors.lastname: Larczynski
authors.forename: Michal
authors.initials: M
authors.lastname: Wozniak
authors.forename: Boleslaw
authors.initials: B
authors.lastname: Rutkowski
mesh_terms: D000328:Adult; D000069059:Atorvastatin; D015237:Dinoprost / Q000031:analogs & derivatives; D005260:Female; D006538:Heptanoic Acids / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D028421:Isoprostanes / Q000652:urine; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000652:urine; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects*; D010919:Placebos; D011758:Pyrroles / Q000494:pharmacology* / Q000627:therapeutic use*
chemical_list: D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D028421:Isoprostanes; D010919:Placebos; D011758:Pyrroles; C075750:8-epi-prostaglandin F2alpha; D000069059:Atorvastatin; D015237:Dinoprost